Hearing on "Fentanyl: The Next Wave of the Opioid Crisis," Subcommittee on Oversight and Investigations (March 21, 2017)
Date:
Location:
2123 Rayburn House Office Building
The Subcommittee on Oversight and Investigations held a hearing on Tuesday, March 21, 2017, at 10:15 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “Fentanyl: The Next Wave of the Opioid Crisis.”
Livestream
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Oversight and Investigations
Opening Statement of Ranking Member Pallone as prepared for delivery
Witnesses
Meeting Documents
Witnesses
Kemp Chester
Acting Director
White House Office of National Drug Control Policy
William Brownfield
Assistant Secretary
Bureau of International Narcotics and Law Enforcement Affairs
U.S. Department of State
Louis Milione
Assistant Administrator
Diversion Control Division
U.S. Drug Enforcement Administration
Matthew Allen
Special Agent in Charge
Homeland Security Investigations
U.S. Immigration and Customs Enforcement
Dr. Wilson Compton
Deputy Director
National Institute on Drug Abuse
National Institutes of Health
Dr. Deborah Houry
Director
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention
Subcommittees
Issues:Health